Solid Tumor, Unspecified, Child

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Blueprint Medicines
Blueprint MedicinesMA - Cambridge
1 program
1
avapritinibPhase 1/2Small Molecule1 trial
Active Trials
NCT04773782Completed29Est. Nov 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Blueprint Medicinesavapritinib

Clinical Trials (1)

Total enrollment: 29 patients across 1 trials

A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Start: Feb 2022Est. completion: Nov 202529 patients
Phase 1/2Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space